Tuesday, 11 September 2018

12 Sept. 2018 Morning Brief

Market may open flat and a bounce-back expected in the session. Nifty has broken it's important support of 11400 and next major support is at 11080 level.

🎯 News & Impact 🎯

🎯 Reliance Capital :
Q1 profit at Rs 111 crore versus loss of Rs.417 crore; revenue falls to Rs 563 crore versus Rs 790 crore (YoY).

🎯 Cipla :
Company received approval for its HIV treatment combination medicine ‘TLD’ from the South African Health Products Regulatory Authority.
Positive for the stock. 👍

🎯 Ajanta Pharma :
Company received U.S. FDA nod for Fenofibrate oral capsule.
Positive for the stock. 👍

🎯 Salzer Electronics :
Promoters increased their stake in the company by 2 % to 36 %.
Positive for the stock. 👍

🎯 Sun Pharma :
Company's Mohali facility is undergoing inspection by U.S. FDA.

🎯 Godrej Agrovet :
Company mulls to merge its subsidiary Astec LifeSciences with self.

🎯 Wipro :
Company appointed as a Europe-based delivery partner for Duck Creek Technologies’ insurance software products. 

🎯 Redington India :
Company to consider share buyback.

🎯 Alembic :
Board has given approval for demerging Identified Real Estate Undertaking of the Company into Shreno Limited.

🎯 Narayana Hrudayalaya :
NH Health Bangladesh Private Limited, a step-down subsidiary of company, has entered into definitive agreements to partner with Imperial Hospital Limited in Chittagong, Bangladesh.

🎯 IL&FS Transport :
CARE and ICRA downgraded IL&FS Transportation’s NCDs and bank loan facilities.

🎯 Adani Green :
Company has incorporated a wholly-owned subsidiary company Adani Saur Urja (KA).

🎯 Satin Creditcare :
Company in next few months will file application with RBI for NBFC license of Satin Finserv.

Edited by Sharp Investment & Financial Advisers

No comments:

Post a Comment